The Association of Plasma Amyloid-β and Cognitive Decline in Cognitively Unimpaired Population

Jin Wang,Ling Gao,Jie Liu,Liangjun Dang,Shan Wei,Ningwei Hu,Yao Gao,Wei Peng,Suhang Shang,Kang Huo,Jingyi Wang,Qiumin Qu
DOI: https://doi.org/10.2147/cia.s357994
IF: 3.829
2022-04-01
Clinical Interventions in Aging
Abstract:Purpose: This study investigates the relationship between baseline plasma Aβ and cognitive decline during follow-up in cognitively unimpaired population.Materials and Methods: Cognitively unimpaired population was selected from people who lived in the suburbs of Xi'an, China. The levels of plasma Aβ<sub>1-42</sub> and Aβ<sub>1-40</sub> were tested using commercial enzyme-linked immunosorbent assay (ELISA). The mini-mental state examination (MMSE) and neuropsychological battery were used to assess cognition. Two years later, MMSE was tested again, and significant cognitive decline was defined as a decrease in MMSE scores ≥5 points. Logistic regression analysis was performed to analyze the relationship between baseline plasma Aβ and cognitive change during the two-year follow-up.Results: A total of 1144 participants completed the study, among whom 59 subjects (5.2%) presented significant cognitive decline. The high plasma Aβ<sub>1-42</sub> level group had more significant cognitive decline (<i>P</i> = 0.023). Multivariable logistic regression analysis showed that significant cognitive decline was associated with the high levels of baseline plasma Aβ<sub>1-42</sub> (OR = 1.043, 95% CI: 1.005-1.083, <i>P</i> = 0.026). However, significant cognitive decline was not associated with baseline plasma Aβ<sub>1-40</sub> levels and Aβ<sub>1-42</sub> /Aβ<sub>1-40</sub> ratio.Conclusion: Population with high level of baseline plasma Aβ<sub>1-42</sub> manifested significant cognitive decline over 2 years; however, further investigation on the dynamics of plasma Aβ and long-term follow-up are needed.
geriatrics & gerontology,gerontology
What problem does this paper attempt to address?